TRENDING TOPICS
83 articles found for "investing"
Core durable goods orders surged 0.9% in January, nearly tripling the 0.3% consensus estimate. The surprise strength is driven by AI infrastructure equipment and data center buildout.
Mass retailers and traditional supermarkets have reached the same 79% grocery penetration for the first time. Walmart's share jumped 6 points in a year as consumers trade down.
Walmart beat Q4 FY2026 estimates with $0.74 EPS and 6% sales growth, but guided FY2027 EPS well below consensus at $2.75-$2.85. The cautious outlook signals a consumer under more stress than the data shows.
More than 30,000 tech workers have been laid off in 2026 as Amazon, Meta, Pinterest, Salesforce, and others cut headcount to invest in AI. The workforce restructuring is accelerating.
Moody's projects real consumer spending growth of just 1.5% in 2026. Lower-income Americans are cutting dining, travel, and fitness as the K-shaped economy widens.
General Mills lowered its full-year profit forecast to a 16-20% decline as consumers cut back on cereal, snacks, and pet food, sending shares down nearly 7%.
The NY Fed's Empire State Manufacturing Index dipped slightly to 7.1 in February from 7.7 in January, showing continued expansion. But input prices jumped to 49.1, the highest since November, raising inflation concerns.
The Employment Cost Index rose just 0.7% in Q4 2025, the weakest quarterly reading since mid-2021, as average hourly earnings growth slowed to 3.7% year-over-year.
USDA projects net farm income will fall to $153.4 billion in 2026, marking the fourth consecutive year of decline. With commodity prices weak, input costs elevated, and debt rising, economists call it a generational downturn.
Allstate is reducing auto and homeowner premiums by an average of 17% for 7.8 million customers after more than doubling net income in 2025. Yet new rate hikes in Illinois and continued turmoil in California paint a picture of a home insurance market still far from stable.
John Deere announced a $20 billion commitment to U.S. manufacturing over the next decade, including two new facilities, even as analysts expect a 40% earnings decline in Q1 2026.
Novo Nordisk's oral Wegovy pill reached 50,000 weekly prescriptions within three weeks of launch at $149 per month, transforming the GLP-1 weight loss market as Eli Lilly forecasts $80 billion in 2026 sales.